Newsbrief: AMT, Foxy Methoxy Permanently Placed on Schedule I 10/15/04

Drug War Chronicle, recent top items


recent blog posts "In the Trenches" activist feed


With a notice in the Federal Register on September 29, the DEA issued a "final rule" placing the psychedelic typtamines Alpha-Methyltryptamine (AMT) and 5-Methoxy-N,N-Diisopropyltryptamine (Foxy Methoxy) in Schedule I of the Controlled Substances Act. It has been illegal to buy, sell, or possess either substance without a DEA license since April 2003, when the agency temporary placed them on Schedule I. The final rule makes permanent the temporary scheduling that took effect last year.

Foxy Methoxy pills, photo from the
National Drug Intelligence Center
Typically, substances may be temporarily scheduled for no more than one year, but in March 2004, the DEA published a notice that proceedings to permanently schedule AMT and Foxy Moxy were underway, thus gaining another six months to do so. That six-month grace period expired two days after the DEA's latest Federal Register notice.

Under the Controlled Substances Act, substances may be classified as Schedule I only if the meet three criteria: that they have a high potential for abuse, no currently accepted medical use in treatment in the United States and are not safe for use under medical supervision. According to the DEA, AMT and Foxy Methoxy meet those criteria. (Never mind for now that the DEA also says that marijuana meets those criteria.)

AMT and Foxy Methoxy share their mind-warping properties with other tryptamines, including DMT and psilocybin. The tryptamines were explored by chemist Sasha Shulgin, who first synthesized Foxy Methoxy in 1981, and who is cited in the DEA's final rule. According to the DEA, AMT has subjective effects similar to amphetamines and MDMA (Ecstasy), while Foxy Methoxy's effects are more akin to those experienced with LSD.

The designer drugs came to the attention of federal regulators in the 1990s, when they began appearing as an adjunct to Ecstasy and other drugs in the European rave scene. In the past several years, the DEA reported, the psychedelic pair crossed the Atlantic, exciting the agency's worry. DEA described the use of AMT and Foxy Methoxy as an "emerging problem" at raves and clubs in Arizona, California, Florida, and New York. AMT and Foxy Methoxy may be an emerging problem, but not a very big one, according to the DEA's own statistics. The agency has filed only 14 AMT cases since 1999 and 32 Foxy Methoxy cases.

With psychedelics such as AMT and Foxy Methoxy, warns the DEA, "the alteration of sensory perception and judgment can pose serious health risks to the user and the general public." And to consensus reality. Find out more about AMT and Foxy Methoxy at the Vault of Erowid's respective web pages for each substance, and online.

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #358, 10/15/04 A Message from the Executive Director on What DRCNet is Planning After Election Day and Why We Need Your Help | Now You See It, Now You Don't: The Amazing Vanishing DEA Pain FAQ | Montana Medical Marijuana Initiative Appears Headed for Victory | Second Medical Marijuana Initiative Faces Tough Fight in Oregon | Medical Marijuana on the Local Ballot in Ann Arbor, Berkeley, Columbia | DRCNet Book Review: "Narcotic Culture: A History of Drugs in China" by Frank Dikotter, Lars Laaman and Zhou Xun (Oxford University Press, $35.00 HB) and "Opium: A Portrait of the Heavenly Demon" by Barbara Hodgson (Greystone Press, $14.95 PB) | Newsbrief: VP Hopeful John Edwards Makes Methamphetamine a Campaign Issue | Newsbrief: AMT, Foxy Methoxy Permanently Placed on Schedule I | Newsbrief: Congress Votes to Double US Troops in Colombia | Newsbrief: European Drug Think Tank Rips US on Afghan Opium Policy -- No "Plan Afghanistan," Please, Says Senlis Council | Newsbrief: Dinosaurs Walk the Earth as Prohibition Party, Independent Candidate Demand Return of Alcohol Prohibition | Newsbrief: This Week's Corrupt Cops Stories | This Week in History | Administrative Assistant: Part-Time Job Opportunity at DRCNet | The Reformer's Calendar

This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]